Halozyme Therapeutics HALO
NASDAQ HALO
$106.94 -3.46 (-3.13%)
At close: Oct 1, 2026 · 4:00 PM EDT

Halozyme Therapeutics (HALO) Other Non-Current Liabilities (2010 - 2026)

Updated

Halozyme Therapeutics' Other Non-Current Liabilities came in at $102.68 million for Q2 2026, up 32.0% from $77.77 million a year earlier but down 3.5% from the prior quarter.

Analysis

Halozyme Therapeutics (HALO) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends

At the end of FY2025, Halozyme Therapeutics' Other Non-Current Liabilities was $113.86 million, up 107.9% from FY2024.

  • Other Non-Current Liabilities has increased in each of the last three years, with a five-year compound annual growth rate of 101.1% (FY2020 to FY2025).
  • Going back by year, Other Non-Current Liabilities was $54.76 million in FY2024 (+45.2%), $37.72 million in FY2023 (+15.4%), $32.69 million in FY2022 and $544,000 in FY2021 (-84.3%).
  • The five-year range for quarterly Other Non-Current Liabilities is $171,000 (Q1 2022) to $130 million (Q2 2022).
  • Year-over-year, Other Non-Current Liabilities has increased for eight consecutive quarters, with growth averaging 78.7% over the last eight quarters.
  • The fastest year-over-year change in Other Non-Current Liabilities over five years came in Q2 2025 (growth of 154.9%), and the weakest in Q1 2022 (a decline of 93.9%).
  • Business Quant data shows HALO's Other Non-Current Liabilities at $106.45 million (Q1 2026), $113.86 million (Q4 2025) and $71.8 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Halozyme Therapeutics 12.59 Bn 11.20 Bn 401.83 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 102.68 Mn
Mar 31, 2026 106.45 Mn
Dec 31, 2025 113.86 Mn
Sep 30, 2025 71.80 Mn
Jun 30, 2025 77.77 Mn
Mar 31, 2025 56.44 Mn
Dec 31, 2024 54.76 Mn
Sep 30, 2024 40.41 Mn
Jun 30, 2024 30.51 Mn
Mar 31, 2024 31.20 Mn
Dec 31, 2023 37.72 Mn
Sep 30, 2023 28.42 Mn
Jun 30, 2023 30.88 Mn
Mar 31, 2023 29.57 Mn
Dec 31, 2022 32.69 Mn
Sep 30, 2022 129.77 Mn
Jun 30, 2022 130.00 Mn
Mar 31, 2022 171,000.00
Dec 31, 2021 544,000.00
Sep 30, 2021 1.61 Mn
API Access

Halozyme Therapeutics Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=HALO&period=max&api_key=YOUR_API_KEY